Imunon, Inc. (IMNN)
1.604
-0.04
(-2.20%)
USD |
NASDAQ |
Aug 24, 16:00
1.604
0.00 (0.00%)
After-Hours: 20:00
Imunon Debt to Equity Ratio : 1.873 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.873 |
| March 31, 2026 | 0.2714 |
| December 31, 2025 | 0.1429 |
| September 30, 2025 | 0.27 |
| June 30, 2025 | 0.4487 |
| March 31, 2025 | 2.230 |
| December 31, 2024 | 0.2684 |
| September 30, 2024 | 0.1546 |
| June 30, 2024 | 0.3713 |
| March 31, 2024 | 0.1775 |
| December 31, 2023 | 0.1214 |
| September 30, 2023 | 0.0961 |
| June 30, 2023 | 0.0633 |
| March 31, 2023 | 0.2842 |
| December 31, 2022 | 0.2137 |
| September 30, 2022 | 0.1539 |
| June 30, 2022 | 0.1373 |
| March 31, 2022 | 0.1415 |
| December 31, 2021 | 0.1189 |
| September 30, 2021 | 0.1132 |
| June 30, 2021 | 0.1045 |
| March 31, 2021 | 0.1115 |
| December 31, 2020 | 0.3329 |
| September 30, 2020 | 0.337 |
| June 30, 2020 | 0.4684 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.6996 |
| December 31, 2019 | 0.7786 |
| September 30, 2019 | 0.7327 |
| June 30, 2019 | 0.601 |
| March 31, 2019 | 0.528 |
| December 31, 2018 | 0.4514 |
| September 30, 2018 | 0.6159 |
| June 30, 2018 | 0.4816 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.241 |
| December 31, 2016 | 0.3807 |
| September 30, 2016 | 0.3399 |
| June 30, 2016 | 0.2773 |
| March 31, 2016 | 0.3606 |
| December 31, 2015 | 0.3151 |
| September 30, 2015 | 0.2919 |
| June 30, 2015 | 0.2801 |
| March 31, 2015 | 0.3349 |
| December 31, 2014 | 0.2957 |
| September 30, 2014 | 0.2464 |
| June 30, 2014 | 0.2126 |
| March 31, 2014 | 0.1233 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Phio Pharmaceuticals Corp. | 0.00 |
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 14.99M |
| Total Liabilities (Quarterly) | 10.80M |
| Shareholders Equity (Quarterly) | 4.189M |
| Current Ratio | 1.819 |
| Net Debt Paydown Yield | -16.47% |